Skip to content
Life Sciences Series A Founded 2007

GlycosBio

Industrial biotechnology company focusing on development of specialty chemicals and food supplements

📍 Houston, United States · Nutraceuticals Tech

Funding snapshot

Last roundSeries A
Amount$1M
Date6 March 2024

About

GlycosBio is a scientifically focused biotechnology company with expertise in molecular biology as well as metabolic engineering. The company leverages metabolic engineering and associated process development for the production of specialty chemicals like Lactic Acid and Isoprene from crude glycerol, palm fatty acid distillates, and glucose for the preparation of food additives, biodegradable plastics, etc. GlycosBio's nutraceuticals platform also supports the production of food ingredients like Non-GMO enriched proteins, dietary fiber, concentrated omega-3 fatty acids and probiotics from rice bran, fish and algal oil, and palm kernel cake.

Latest news

No articles yet.

Raising like GlycosBio?

Analyze your pitch deck before your next raise.

Analyze My Deck →